Cargando…

Vascular Immune Evasion of Mesenchymal Glioblastoma Is Mediated by Interaction and Regulation of VE-Cadherin on PD-L1

SIMPLE SUMMARY: Our study identified the primary expression of PD-L1 in vascular endothelial cells that correlated with the expression of the mesenchymal markers YKL-40 and Vim and poor patient survival. YKL-40 induced VE-cad expression, which interacted with and upregulated PD-L1, leading to vascul...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Jing, Wang, Ziyi, Zhang, Xuemei, Yu, Haihui, Chen, Hui, Song, Kun, Zhang, Yang, Schwartz, Lawrence M., Chen, Hongzhuan, Liu, Yingbin, Shao, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486786/
https://www.ncbi.nlm.nih.gov/pubmed/37686533
http://dx.doi.org/10.3390/cancers15174257
_version_ 1785103089744740352
author Luo, Jing
Wang, Ziyi
Zhang, Xuemei
Yu, Haihui
Chen, Hui
Song, Kun
Zhang, Yang
Schwartz, Lawrence M.
Chen, Hongzhuan
Liu, Yingbin
Shao, Rong
author_facet Luo, Jing
Wang, Ziyi
Zhang, Xuemei
Yu, Haihui
Chen, Hui
Song, Kun
Zhang, Yang
Schwartz, Lawrence M.
Chen, Hongzhuan
Liu, Yingbin
Shao, Rong
author_sort Luo, Jing
collection PubMed
description SIMPLE SUMMARY: Our study identified the primary expression of PD-L1 in vascular endothelial cells that correlated with the expression of the mesenchymal markers YKL-40 and Vim and poor patient survival. YKL-40 induced VE-cad expression, which interacted with and upregulated PD-L1, leading to vascular immune escape. In addition, upregulated VE-cad drove CCR5-mediated tumor vascularization. These data may offer solid evidence to decipher molecular mechanisms that contribute to the rigorous resistance of mesenchymal GBM to single anti-immune or angiogenic therapies. Therefore, our findings suggest a novel therapeutic strategy that combines treatments targeting both YKL-40 and VE-cad/or PD-L1 facilitates the blockade of anti-vascular immune evasion and tumor angiogenesis, benefiting patients with mesenchymal GBM. ABSTRACT: The mesenchymal subtype of glioblastoma (mGBM), which is characterized by rigorous vasculature, resists anti-tumor immune therapy. Here, we investigated the mechanistic link between tumor vascularization and the evasion of immune surveillance. Clinical datasets with GBM transcripts showed that the expression of the mesenchymal markers YKL-40 (CHI3L1) and Vimentin is correlated with elevated expression of PD-L1 and poor disease survival. Interestingly, the expression of PD-L1 was predominantly found in vascular endothelial cells. Orthotopic transplantation of glioma cells GL261 over-expressing YKL-40 in mice showed increased angiogenesis and decreased CD8+ T cell infiltration, resulting in a reduction in mouse survival. The exposure of recombinant YKL-40 protein induced PD-L1 and VE-cadherin (VE-cad) expression in endothelial cells and drove VE-cad-mediated nuclear translocation of β-catenin/LEF, where LEF upregulated PD-L1 expression. YKL-40 stimulated the dissociation of VE-cad from PD-L1, rendering PD-L1 available to interact with PD-1 from CD8+-positive TALL-104 lymphocytes and inhibit TALL-104 cytotoxicity. YKL-40 promoted TALL-104 cell migration and adhesion to endothelial cells via CCR5-dependent chemotaxis but blocked its anti-vascular immunity. Knockdown of VE-cad or the PD-L1 gene ablated the effects of YKL-40 and reinvigorated TALL-104 cell immunity against vessels. In summary, our study demonstrates a novel vascular immune escape mechanism by which mGBM promotes tumor vascularization and malignant transformation.
format Online
Article
Text
id pubmed-10486786
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104867862023-09-09 Vascular Immune Evasion of Mesenchymal Glioblastoma Is Mediated by Interaction and Regulation of VE-Cadherin on PD-L1 Luo, Jing Wang, Ziyi Zhang, Xuemei Yu, Haihui Chen, Hui Song, Kun Zhang, Yang Schwartz, Lawrence M. Chen, Hongzhuan Liu, Yingbin Shao, Rong Cancers (Basel) Article SIMPLE SUMMARY: Our study identified the primary expression of PD-L1 in vascular endothelial cells that correlated with the expression of the mesenchymal markers YKL-40 and Vim and poor patient survival. YKL-40 induced VE-cad expression, which interacted with and upregulated PD-L1, leading to vascular immune escape. In addition, upregulated VE-cad drove CCR5-mediated tumor vascularization. These data may offer solid evidence to decipher molecular mechanisms that contribute to the rigorous resistance of mesenchymal GBM to single anti-immune or angiogenic therapies. Therefore, our findings suggest a novel therapeutic strategy that combines treatments targeting both YKL-40 and VE-cad/or PD-L1 facilitates the blockade of anti-vascular immune evasion and tumor angiogenesis, benefiting patients with mesenchymal GBM. ABSTRACT: The mesenchymal subtype of glioblastoma (mGBM), which is characterized by rigorous vasculature, resists anti-tumor immune therapy. Here, we investigated the mechanistic link between tumor vascularization and the evasion of immune surveillance. Clinical datasets with GBM transcripts showed that the expression of the mesenchymal markers YKL-40 (CHI3L1) and Vimentin is correlated with elevated expression of PD-L1 and poor disease survival. Interestingly, the expression of PD-L1 was predominantly found in vascular endothelial cells. Orthotopic transplantation of glioma cells GL261 over-expressing YKL-40 in mice showed increased angiogenesis and decreased CD8+ T cell infiltration, resulting in a reduction in mouse survival. The exposure of recombinant YKL-40 protein induced PD-L1 and VE-cadherin (VE-cad) expression in endothelial cells and drove VE-cad-mediated nuclear translocation of β-catenin/LEF, where LEF upregulated PD-L1 expression. YKL-40 stimulated the dissociation of VE-cad from PD-L1, rendering PD-L1 available to interact with PD-1 from CD8+-positive TALL-104 lymphocytes and inhibit TALL-104 cytotoxicity. YKL-40 promoted TALL-104 cell migration and adhesion to endothelial cells via CCR5-dependent chemotaxis but blocked its anti-vascular immunity. Knockdown of VE-cad or the PD-L1 gene ablated the effects of YKL-40 and reinvigorated TALL-104 cell immunity against vessels. In summary, our study demonstrates a novel vascular immune escape mechanism by which mGBM promotes tumor vascularization and malignant transformation. MDPI 2023-08-25 /pmc/articles/PMC10486786/ /pubmed/37686533 http://dx.doi.org/10.3390/cancers15174257 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Luo, Jing
Wang, Ziyi
Zhang, Xuemei
Yu, Haihui
Chen, Hui
Song, Kun
Zhang, Yang
Schwartz, Lawrence M.
Chen, Hongzhuan
Liu, Yingbin
Shao, Rong
Vascular Immune Evasion of Mesenchymal Glioblastoma Is Mediated by Interaction and Regulation of VE-Cadherin on PD-L1
title Vascular Immune Evasion of Mesenchymal Glioblastoma Is Mediated by Interaction and Regulation of VE-Cadherin on PD-L1
title_full Vascular Immune Evasion of Mesenchymal Glioblastoma Is Mediated by Interaction and Regulation of VE-Cadherin on PD-L1
title_fullStr Vascular Immune Evasion of Mesenchymal Glioblastoma Is Mediated by Interaction and Regulation of VE-Cadherin on PD-L1
title_full_unstemmed Vascular Immune Evasion of Mesenchymal Glioblastoma Is Mediated by Interaction and Regulation of VE-Cadherin on PD-L1
title_short Vascular Immune Evasion of Mesenchymal Glioblastoma Is Mediated by Interaction and Regulation of VE-Cadherin on PD-L1
title_sort vascular immune evasion of mesenchymal glioblastoma is mediated by interaction and regulation of ve-cadherin on pd-l1
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486786/
https://www.ncbi.nlm.nih.gov/pubmed/37686533
http://dx.doi.org/10.3390/cancers15174257
work_keys_str_mv AT luojing vascularimmuneevasionofmesenchymalglioblastomaismediatedbyinteractionandregulationofvecadherinonpdl1
AT wangziyi vascularimmuneevasionofmesenchymalglioblastomaismediatedbyinteractionandregulationofvecadherinonpdl1
AT zhangxuemei vascularimmuneevasionofmesenchymalglioblastomaismediatedbyinteractionandregulationofvecadherinonpdl1
AT yuhaihui vascularimmuneevasionofmesenchymalglioblastomaismediatedbyinteractionandregulationofvecadherinonpdl1
AT chenhui vascularimmuneevasionofmesenchymalglioblastomaismediatedbyinteractionandregulationofvecadherinonpdl1
AT songkun vascularimmuneevasionofmesenchymalglioblastomaismediatedbyinteractionandregulationofvecadherinonpdl1
AT zhangyang vascularimmuneevasionofmesenchymalglioblastomaismediatedbyinteractionandregulationofvecadherinonpdl1
AT schwartzlawrencem vascularimmuneevasionofmesenchymalglioblastomaismediatedbyinteractionandregulationofvecadherinonpdl1
AT chenhongzhuan vascularimmuneevasionofmesenchymalglioblastomaismediatedbyinteractionandregulationofvecadherinonpdl1
AT liuyingbin vascularimmuneevasionofmesenchymalglioblastomaismediatedbyinteractionandregulationofvecadherinonpdl1
AT shaorong vascularimmuneevasionofmesenchymalglioblastomaismediatedbyinteractionandregulationofvecadherinonpdl1